This review examines lignin-derived biopharmaceuticals, highlighting their potential and challenges for future applications.
Lignin, a renewable and widespread aromatic biopolymer constituting 15-40% of the dry weight of lignocellulosic biomass, is a principal component of plant cell walls. Its inherent properties, including biocompatibility, antioxidant...
No takes yet. Share an insight, caveat, or question.
Rawat et al. (2026) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: